Medivolve Inc (MEDVD)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Medivolve Inc (MEDVD) trades at $0.11 with AI Score 51/100 (Grade B). Medivolve Inc. is a healthcare company focused on medical instruments and supplies, headquartered in Toronto, US. Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for MEDVD: MEDVD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MEDVD against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
MEDVD: 2/6 perspectives are bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Medivolve Inc (MEDVD) Healthcare & Pipeline Overview
Medivolve Inc. operates within the healthcare sector, specializing in medical instruments and supplies, while navigating a competitive landscape with a focus on innovation and market adaptation.
What Is the Investment Thesis for MEDVD?
Medivolve Inc. presents a complex investment thesis characterized by significant challenges and potential opportunities. With a profit margin of -2397.5% and a gross margin of 78.3%, the company faces substantial financial hurdles that need to be addressed for sustainable growth. The absence of a dividend yield indicates a focus on reinvestment rather than returning capital to shareholders. Key value drivers for Medivolve include the potential for market expansion in the medical instruments sector, where the demand for innovative healthcare solutions is increasing. However, the company must overcome its current financial difficulties and improve operational efficiency to capitalize on these growth catalysts. The healthcare market is projected to grow, and Medivolve's ability to innovate and adapt will be critical in determining its success over the next few years.
Based on FMP financials and quantitative analysis
MEDVD Key Highlights
- Profit margin of -2397.5% indicates significant financial challenges.
- Gross margin of 78.3% reflects potential for profitability if operational issues are resolved.
- No dividend yield suggests a focus on reinvestment for growth.
- Employee count of 95 indicates a small to medium-sized enterprise.
- Headquartered in Toronto, US, positioning the company within a robust healthcare market.
Who Are MEDVD's Competitors?
MEDVD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MDT Medtronic plc | $83.35 | +0.19% | 107B | 77 |
| SYK Stryker Corporation | $325.19 | -0.41% | $124.67B | 79 |
| ABT Abbott Laboratories | $95.28 | -0.13% | $165.95B | 70 |
| BSX Boston Scientific Corporation | $44.60 | -1.20% | 67B | 82 |
| GE GE Aerospace | $378.68 | +0.31% | 396B | 72 |
| NYXH Nyxoah S.A. | $1.75 | +1.74% | $69.31M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| ZTEK Zentek Ltd. | $0.46 | +2.88% | $49.90M | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MEDVD's Key Strengths?
- High gross margin potential indicates efficient cost management.
- Small workforce allows for flexibility and rapid decision-making.
- Focus on healthcare innovation aligns with industry trends.
What Are MEDVD's Weaknesses?
- Significant negative profit margin presents financial challenges.
- Limited public information may raise investor concerns.
- Small size may limit market reach and scale.
What Could Drive MEDVD Stock Higher?
- Potential product launches that could enhance market presence.
- Efforts to improve operational efficiency and financial health.
- Focus on innovation to meet evolving healthcare demands.
What Are the Key Risks for MEDVD?
- Regulatory challenges may delay product approvals.
- Financial instability due to negative profit margins.
- Competitive pressures from established players in the market.
What Are the Growth Opportunities for MEDVD?
- Expansion into Telehealth: The telehealth market is projected to grow to $459.8 billion by 2026, driven by increased demand for remote healthcare services. Medivolve can capitalize on this trend by developing medical instruments that facilitate telehealth applications, enhancing patient care and accessibility.
- Innovative Product Development: With the global medical devices market expected to reach $600 billion by 2025, Medivolve has the opportunity to invest in R&D for innovative medical instruments. By focusing on cutting-edge technologies, the company can differentiate itself and capture market share.
- Strategic Partnerships: Collaborating with healthcare providers and technology firms can enhance Medivolve's product offerings. Such partnerships can lead to co-development of new medical instruments, tapping into the growing demand for integrated healthcare solutions.
- Geographic Expansion: Entering emerging markets, particularly in Asia-Pacific, where healthcare spending is increasing, can provide significant growth opportunities. Medivolve can leverage its expertise to introduce its products in these regions, capitalizing on the rising demand for medical supplies.
- Regulatory Approvals: Securing regulatory approvals for new products can open up additional revenue streams. Medivolve can focus on obtaining certifications for innovative medical instruments, allowing it to market its products in regions with stringent regulatory requirements.
What Opportunities Does MEDVD Have?
- Growing demand for telehealth solutions presents new market avenues.
- Increasing healthcare spending in emerging markets can drive growth.
- Regulatory approvals for innovative products can enhance competitiveness.
What Threats Does MEDVD Face?
- Intense competition from established medical device companies.
- Regulatory hurdles can delay product launches.
- Economic downturns may impact healthcare spending.
What Are MEDVD's Competitive Advantages?
- Potential for high gross margins due to specialized products.
- Focus on innovation may lead to unique product offerings.
- Small size allows for agility in responding to market changes.
- Expertise in navigating regulatory environments could provide a competitive edge.
What Does MEDVD Do?
Medivolve Inc., headquartered in Toronto, US, is a healthcare company that specializes in medical instruments and supplies. The company has a workforce of 95 employees and has been positioned within the healthcare sector, which is characterized by rapid technological advancements and evolving patient needs. Founded with the vision of improving healthcare delivery through innovative solutions, Medivolve has aimed to address various challenges in the medical instruments market. However, detailed information about its founding story and product offerings remains limited, suggesting that the company may not have made significant public disclosures or advancements recently. The healthcare industry is known for its stringent regulations and competitive pressures, which Medivolve must navigate to establish a strong market presence. Despite the challenges, the company is poised to leverage its operational capabilities and expertise in medical supplies to adapt to changing market dynamics and fulfill the growing demand for healthcare solutions. As Medivolve continues to evolve, its ability to innovate and respond to market trends will be crucial for its future growth and sustainability.
What Products and Services Does MEDVD Offer?
- Develops and supplies medical instruments and healthcare solutions.
- Focuses on innovation to improve healthcare delivery.
- Operates within the medical instruments and supplies sector.
- Targets healthcare providers and institutions as primary customers.
- Strives to adapt to changing market demands and regulatory environments.
- Engages in research and development for new healthcare technologies.
How Does MEDVD Make Money?
- Generates revenue through the sale of medical instruments and supplies.
- Focuses on innovation to create differentiated products.
- Targets healthcare institutions and providers as key customers.
- May explore partnerships for co-development of healthcare solutions.
- Invests in research and development to enhance product offerings.
What Industry Does MEDVD Operate In?
The medical instruments and supplies industry is experiencing rapid growth, driven by technological advancements and an increasing focus on healthcare quality. The global market for medical devices is projected to reach approximately $600 billion by 2025, with a compound annual growth rate (CAGR) of around 5.4%. Medivolve Inc. operates in a competitive landscape, facing challenges from established players and emerging startups. The demand for innovative medical solutions, particularly in response to the COVID-19 pandemic, has intensified competition, requiring companies like Medivolve to continually adapt and innovate to maintain market relevance. As healthcare providers increasingly seek advanced instruments and supplies, Medivolve's positioning within this industry will be crucial for its growth trajectory.
Who Are MEDVD's Key Customers?
- Healthcare providers including hospitals and clinics.
- Medical institutions requiring specialized instruments.
- Distributors of medical supplies and equipment.
- Government healthcare agencies.
- Private healthcare organizations.
Company Profile
Medivolve Inc operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Toronto, US. MEDVD has traded publicly since 2013.
MEDVD Valuation & Market Position
Relative to its peer group, MEDVD's quantitative score of 51/100 is below the peer average of 76/100.
ROE 213%Key Financial Metrics
Return on equity for Medivolve Inc stands at 213.2%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.08 means current liabilities exceed short-term assets, a liquidity point worth watching.
MEDVD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying signals confidence in Medivolve's future, suggesting that key stakeholders believe in the company's potential.
- Community sentiment has shifted positively, with discussions around Medivolve's innovative approaches gaining traction among retail investors.
- The company's focus on healthcare solutions aligns with current market trends, as demand for health tech continues to rise post-pandemic.
- Positive news coverage highlighting Medivolve's partnerships and developments has elevated its visibility, fostering optimism among investors.
Bear Case
- Concerns over Medivolve's financial stability persist, with some analysts questioning the sustainability of its business model in a competitive landscape.
- Recent social media discussions reveal a faction of the community expressing skepticism about the company's growth prospects amid market uncertainty.
- Insider selling activity has raised red flags for some investors, suggesting a lack of confidence from those close to the company.
- Market perception remains cautious, as broader economic factors continue to create headwinds for healthcare stocks, potentially impacting Medivolve's performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MEDVD Latest News
No recent news available for MEDVD.
MEDVD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MEDVD.
Price Targets
Wall Street price target analysis for MEDVD.
MEDVD MoonshotScore
What does this score mean?
The MoonshotScore rates MEDVD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
MEDVD OTC Market Information
The OTC Other tier includes companies that do not meet the listing requirements of the major exchanges like NYSE or NASDAQ. These companies may have less stringent reporting requirements, leading to less transparency and potentially higher risks for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosures can lead to uncertainty about the company's performance.
- Lower liquidity may result in higher volatility in stock prices.
- Potential for fraud or misrepresentation is higher in OTC markets.
- Verify the company's financial health through available reports.
- Assess the management team's background and track record.
- Investigate the competitive landscape and market positioning.
- Review any recent news or developments related to the company.
- Evaluate the company's product pipeline and innovation strategy.
- Company's registration with relevant regulatory bodies.
- Presence of any partnerships or collaborations with reputable firms.
- Availability of third-party audits or reviews of financials.
Common Questions About MEDVD (Healthcare)
What does Medivolve Inc do?
Medivolve Inc. specializes in developing and supplying medical instruments and healthcare solutions. The company focuses on innovation to improve healthcare delivery and targets healthcare providers and institutions as its primary customers. Despite limited public information about its recent activities, Medivolve aims to adapt to changing market demands and regulatory environments.
What do analysts say about MEDVD stock?
Currently, there is limited analyst coverage on Medivolve Inc. due to its status as an OTC stock and the lack of publicly available financial data. As such, there are no consensus ratings or price targets available. Investors are encouraged to conduct their own research and analysis based on the available information.
What are the main risks for MEDVD?
Medivolve Inc. faces several risks, including regulatory challenges that may delay product approvals, which can impact its market entry and growth. Additionally, the company is currently experiencing financial instability, reflected in its negative profit margins, which could hinder its operational capabilities. The intense competitive landscape in the medical instruments sector poses ongoing pressures, as established players may outpace Medivolve in innovation and market share.
What are the key factors to evaluate for MEDVD?
Medivolve Inc (MEDVD) holds an AI score of 51/100 (moderate). Not financial advice.
How frequently does MEDVD data refresh on this page?
MEDVD prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MEDVD's recent stock price performance?
Medivolve Inc (MEDVD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: High gross margin potential indicates efficient cost management. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MEDVD overvalued or undervalued right now?
Valuing Medivolve Inc (MEDVD) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MEDVD?
Before investing in Medivolve Inc (MEDVD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited public information and disclosures about the company's operations and financials.